Endocarditis and Erythema multiforme

Summary:

Erythema multiforme is found among people with Endocarditis, especially for people who are male, 60+ old.

The study analyzes which people have Erythema multiforme with Endocarditis. It is created by eHealthMe based on reports of 33 people who have Endocarditis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Endocarditis?

Endocarditis (inflammation in heart muscle) is found to be associated with 648 drugs and 824 conditions by eHealthMe. Check the latest studies of Endocarditis.

What is Erythema multiforme?

Erythema multiforme (a type of hypersensitivity reaction) is found to be associated with 1,693 drugs and 2,922 conditions by eHealthMe. Check the latest studies of Erythema multiforme.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

33 people who have Endocarditis and Erythema Multiforme are studied.

Would you have Erythema multiforme when you have Endocarditis?

Gender of people who have Endocarditis and experienced Erythema Multiforme *:

female: 36.67 %
male: 63.33 %

Age of people who have Endocarditis and experienced Erythema Multiforme *:

Common co-existing conditions for these people *:

Septic Shock (shock due to blood infection): 9 people, 27.27%
Infection: 4 people, 12.12%
Aspergillosis (an infection caused by a fungus called aspergillus): 3 people, 9.09%
Pain: 3 people, 9.09%
Itching: 3 people, 9.09%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 2 people, 6.06%
Stomatitis (inflammation of mucous membrane of mouth): 2 people, 6.06%
Sleep Disorder: 2 people, 6.06%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 6.06%
Cytomegalovirus Infection: 2 people, 6.06%

Common drugs taken by these people *:

Common symptoms for these people *:

Drug Ineffective: 8 people, 24.24%
Enterococcal Infection: 7 people, 21.21%
Thrombocytopenia (decrease of platelets in blood): 6 people, 18.18%
Necrosis (the death of body tissue): 6 people, 18.18%
Cardiac Arrest: 6 people, 18.18%
Chronic Kidney Disease: 6 people, 18.18%
Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery): 6 people, 18.18%
Anaemia (lack of blood): 6 people, 18.18%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 6 people, 18.18%
Septic Shock (shock due to blood infection): 6 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Erythema multiforme?

- Check whether Erythema multiforme is associated with a drug or a condition

Related publications that referenced our studies

Tognetti L, Giorgini S, Lotti T, "Erythema multiforme-like eruption from a slimming drug preparation cutaneous adverse drug reaction", Indian dermatology online journal, 2011 Jan .
Tognetti L, Giorgini S, Lotti T, "Erythema multiforme-like eruption from a slimming drug preparation cutaneous adverse drug reaction", Indian dermatology online journal, 2011 Jan .

Related studies:

Treatments, associated drugs and conditions:

Endocarditis (9,259 reports)
Erythema multiforme (56,072 reports)

All the drugs that are associated with Erythema multiforme:

Erythema multiforme (1,693 drugs)

All the conditions that are associated with Erythema multiforme:

Erythema multiforme (2,922 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Erythema multiforme and Endocarditis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.